Considerations for Antimicrobial Selection in Clostridioides difficile InfectionConference Highlights
This educational program is designed for infectious disease pharmacists interested in the treatment of CDI. Dr. Paul Feuerstadt and Dr. Kevin Garey discuss community and healthcare-associated infections, recent updates to guidelines, and evidence-based selection of antimicrobial therapy for the treatment of initial infection and prevention of recurrence. What happens if the patient returns with recurrence? Watch to find out as the faculty discuss a patient case highlighting the risks of recurrence and selection of therapy.
Faculty: Paul Feuerstadt, MD, FACG, AGAF; Kevin W. Garey, PharmD, MS
Expiration Date: November 12, 2022
CME/CE is no longer available for this activity